What is chronic inflammatory response syndrome (CIRS) and how should it be evaluated and treated?

Chronic Inflammatory Response Syndrome (CIRS) - Evaluation and Treatment

Chronic Inflammatory Response Syndrome (CIRS) is a controversial diagnosis not recognized in mainstream medical guidelines; the provided evidence consists entirely of rhinosinusitis guidelines that do not address CIRS, and limited case reports describing CIRS as a biotoxin-related illness from water-damaged buildings with only one documented treatment protocol (the Shoemaker Protocol) showing any clinical efficacy.

What CIRS Proponents Claim It Is

CIRS is described in limited research literature as an acquired condition characterized by innate immune dysregulation following respiratory exposure to water-damaged buildings, particularly mold toxins (mycotoxins). The condition allegedly affects up to 25% of the population and involves multisystem symptoms including fatigue, cognitive dysfunction, and chronic inflammation 1, 2.

Critical Context: None of the major medical guidelines provided (American Academy of Otolaryngology 2025, European Position Paper on Rhinosinusitis 2020, ESMO, SCCM/ESICM) recognize or mention CIRS as a clinical entity 3, 4, 5, 6. This is a significant red flag regarding its validity as a distinct medical diagnosis.

Proposed Diagnostic Approach (Based on Limited Evidence)

According to the sparse literature available:

Clinical History

• Detailed mold exposure assessment: Current home, past residences, workplace water damage 2
• Symptom inventory: Fatigue, cognitive impairment, multisystem complaints
• Genetic susceptibility: HLA-DR/DQ haplotype testing (claimed to identify susceptible individuals) 7

Laboratory Testing (Per CIRS Literature)

• Inflammatory biomarkers: TGF-β1 (transforming growth factor beta-1), MMP-9 (matrix metalloproteinase-9) 8
• Vasoactive intestinal peptide (VIP): Claimed to be clinically undetectable in CIRS 7
• Urine mycotoxin panels: For trichothecene and other mycotoxins 7
• Visual contrast sensitivity (VCS) testing: Claimed to show abnormalities 8

Important Caveat: These tests lack validation in mainstream medical literature and are not part of standard diagnostic workups for inflammatory conditions.

Treatment Evidence

The Only Protocol with Documented Outcomes

The Shoemaker Protocol was the only treatment showing documented clinical efficacy in the literature review, appearing in 11 of 13 CIRS treatment articles 1. This protocol includes:

1. Environmental remediation: Elimination of biotoxin exposures (removal from water-damaged buildings)
2. VIP replacement therapy
3. Cholestyramine: Bile acid sequestrant claimed to bind mycotoxins
4. Mind-body interventions: Relaxation response programs 7

Alternative Approaches with Limited Evidence

• Hyperbaric oxygen therapy (HBOT): One case report showed symptom resolution and biomarker improvement after 40 sessions over 10 weeks, but this is extremely weak evidence (single patient, no controls) 8

Critical Analysis and Recommendations

Why This Diagnosis Is Problematic

1. Absence from major guidelines: No recognition in otolaryngology, rheumatology, immunology, or critical care guidelines despite extensive discussion of chronic inflammatory conditions 3, 4, 5, 6

2. Confusion with established diagnoses: The evidence shows CIRS symptoms overlap significantly with:

   • Chronic rhinosinusitis (CRS) - which HAS established diagnostic criteria and treatment 4, 5, 6
   • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) 1
   • Primary headache disorders 4
   • Immune deficiencies 4

3. Weak evidence base: Only case reports and retrospective reviews, no randomized controlled trials 8, 1, 7

What You Should Actually Do

If a patient presents with suspected "CIRS," evaluate for established medical conditions first:

Rule Out Chronic Rhinosinusitis

• Diagnostic criteria: ≥12 weeks of two or more symptoms (nasal obstruction, nasal discharge, facial pain/pressure, reduced smell) PLUS objective documentation via nasal endoscopy or CT showing mucosal inflammation 5, 6
• Treatment: Saline irrigation and topical intranasal corticosteroids 5, 6, 9

Assess for Immune Deficiency

• When to test: History of frequent infections, recurrent acute rhinosinusitis 4
• Basic workup: Complete blood count with eosinophils, specific IgE for common allergens, serum IgE, immunoglobulin levels 4

Consider Primary Headache Disorders

• Facial pain without nasal symptoms or examination abnormalities suggests migraine, not sinus disease 4
• Treatment: Amitriptyline and/or triptans, neurology referral 4

Evaluate for Allergic Rhinitis

• Testing for allergy may be obtained in patients with chronic upper airway symptoms 5, 6

Bottom Line for Clinical Practice

Do not diagnose "CIRS" without first completing a thorough evaluation for established medical conditions with evidence-based treatments. The absence of this diagnosis from all major medical society guidelines, combined with only case-report level evidence for its treatment, means it should not be a primary diagnosis. Focus on identifying and treating recognized conditions like chronic rhinosinusitis, immune deficiencies, and primary headache disorders that have validated diagnostic criteria and proven therapies.

If environmental mold exposure is documented and symptoms persist despite treating established conditions, environmental remediation is reasonable, but avoid unvalidated testing (mycotoxin panels, VCS testing) and unproven treatments beyond this.